Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30072831HIVENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TVIS20013361HPVENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TVIS20035516HPVENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TVIS44028007HTLV-1ENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TVIS44028008HTLV-1ENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TVIS44028009HTLV-1ENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TVIS44028010HTLV-1ENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TVIS44034783HTLV-1ENSG00000130234.13protein_codingACE2NoNo59272Q9BYF1
TCGA Plot Options
Drug Information
GeneACE2
DrugBank IDDB09019
Drug NameBromhexine
Target IDBE0000982
UniProt IDQ9BYF1
Regulation Typebinder
PubMed IDs32995775; 33045350
CitationsOlaleye OA, Kaur M, Onyenaka CC: Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2. bioRxiv. 2020 Sep 14. doi: 10.1101/2020.09.13.295691.@@Alkotaji M: Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2. Int J Antimicrob Agents. 2020 Dec;56(6):106192. doi: 10.1016/j.ijantimicag.2020.106192. Epub 2020 Oct 10.
GroupsApproved
Direct ClassificationPhenylmethylamines
SMILESCN(CC1=CC(Br)=CC(Br)=C1N)C1CCCCC1
Pathways
PharmGKB
ChEMBLCHEMBL253376